Mark A. Ator - Concepedia

Author

Mark A. Ator

Brandywine Photonics (United States)

Also Known As

Ator, Mark A., M A Ator, M Ator, M. A. ATOR, M. A. Ator, M. ATOR, M. Ator, M.A. Ator, MARK A. ATOR, Mark A Ator

138

Publications

4.4K

Citations

H-Index

110

Concepts

All Affiliations

Brandywine Photonics (United States)Teva Pharmaceuticals (United States)South College Sterling Research Group University of California, San Francisco

About

Mark A. Ator is an author at Brandywine Photonics (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	47	1.8K
2	Biochemistry	19	26	1.1K
3	Natural Sciences	18	23	977
4	Public Health	1	1	33
5	Allergy	1	1	53

Mark A. Ator

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Protein control of prosthetic heme reactivity. Reaction of substrates with the heme edge of horseradish peroxidase. Mark A. Ator, P.R. Ortiz de Montellano Journal of Biological Chemistry	1987	218
P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme Roland E. Dolle, C. V. C. Prasad, Stanley J. Schmidt, Journal of Medicinal Chemistry Interleukin-1.beta.-converting EnzymeImmunologyAltmetric Attention ScorePeptide ScienceChemical Biology	1994	146
Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee, Journal of Medicinal Chemistry	2008	146
Mechanism-based inactivation of horseradish peroxidase by sodium azide. Formation of meso-azidoprotoporphyrin IX Paul R. Ortiz de Montellano, Shantha David, Mark A. Ator, Biochemistry	1988	142
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor Joel Kaye, Victor Piryatinsky, Tal Birnberg, Proceedings of the National Academy of Sciences	2016	133
Pre-Steady-State and Steady-State Kinetic Analysis of <i>E. coli</i> Class I Ribonucleotide Reductase Jie Ge, Guixue Yu, Mark A. Ator, Biochemistry	2003	128
Structure and catalytic mechanism of horseradish peroxidase. Regiospecific meso alkylation of the prosthetic heme group by alkylhydrazines. Mark A. Ator, Shantha David, P.R. Ortiz de Montellano Journal of Biological Chemistry Bioorganic ChemistryOrganic ChemistryChemistryChemical BiologyRedox Biology	1987	126
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity Sheila Miknyoczki, Hong Chang, Jennifer V. Grobelny, Molecular Cancer Therapeutics	2007	110
Application of Genetic Algorithms to Combinatorial Synthesis: A Computational Approach to Lead Identification and Lead Optimization<sup>,</sup> Jasbir Singh, Mark A. Ator, Edward P. Jaeger, Journal of the American Chemical Society	1996	109
Mechanism of ribonucleoside diphosphate reductase from Escherichia coli. Evidence for 3'-C--H bond cleavage. J. Stubbe, Mark A. Ator, Thomas A. Krenitsky Journal of Biological Chemistry	1983	105

Page 1